BPI-371153, an orally bioavailable small molecule PD-L1 inhibitor

被引：0

作者：

Wang, Yiqian ^{[1
]}

Jing, Xiangyan ^{[1
]}

Chen, Hong ^{[1
]}

Zhang, Huijuan ^{[1
]}

Ma, Tianyi ^{[1
]}

Zhang, Yao ^{[1
]}

Zhang, Chunhui ^{[1
]}

Zhang, Guangzhi ^{[1
]}

Liu, Xiangyong ^{[1
]}

Yan, Dan ^{[1
]}

Guo, Jing ^{[1
]}

Lan, Hong ^{[1
]}

Wang, Jiabing ^{[1
]}

Ding, Lieming ^{[2
]}

机构：

[1] Betta Pharmaceut Co LTD, Beijing, Peoples R China

[2] Betta Pharmaceut Co LTD, Hangzhou, Peoples R China

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5444

引用

页数：2

共 50 条

[31] Novel small-molecule antagonists of the PD1/PD-L1 axis
Magnez, Romain
Leleu-Chavain, Natascha
Tardy, Morgane
El Bouazzati, Hassiba
Klupsch, Frederique
Bailly, Christian
Millet, Regis
Quesnel, Bruno
Thuru, Xavier
CANCER RESEARCH, 2020, 80 (16)
[32] Novel, small molecule inhibitors of PD-L1/PD-1 interaction.
Sivanandhan, Dhanalakshmi
Rajagopal, Sridharan
Naveen, Sadhu M.
Gajendran, Chandru
Venkateshappa, Chandregowda
Reddy, Muralidhar
Kishore, Pendyala Satya
Deshpande, Pratima
Kannan, Sundarajan
Sahareen, Tabassum
Viswakarma, Santhosh
Siddiqui, Amir
Zainuddin, Mohammed
Rudresh, G.
Daram, Prashanthi
Gosu, Ramchandraiah
Devi, Rashmi Rekha
CANCER RESEARCH, 2021, 81 (13)
[33] Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway
Wu, Qian
Jiang, Li
Li, Si-cheng
He, Qiao-jun
Yang, Bo
Cao, Ji
ACTA PHARMACOLOGICA SINICA, 2021, 42 (01) : 1 - 9
[34] Comprehensive in vitro characterization of PD-L1 small molecule inhibitors
Aravindhan Ganesan
Marawan Ahmed
Isobel Okoye
Elena Arutyunova
Dinesh Babu
William L. Turnbull
Joydeb Kumar Kundu
Justin Shields
Katharine Cheryl Agopsowicz
Lai Xu
Yasser Tabana
Nutan Srivastava
Guangzhi Zhang
Tae Chul Moon
Alexandr Belovodskiy
Mostofa Hena
Appan Srinivas Kandadai
Seyedeh Nargess Hosseini
Mary Hitt
John Walker
Michael Smylie
Frederick G. West
Arno G. Siraki
M. Joanne Lemieux
Shokrollah Elahi
James A. Nieman
D. Lorne Tyrrell
Michael Houghton
Khaled Barakat
Scientific Reports, 9
[35] Novel, small molecule PD-L1 inhibitors for cancer immunotherapy
Sivanandhan, D.
Garapaty, S.
Seerapu, G. P.
Das, R.
Kar, R.
Singh, A. K.
Kumar, V. Ashok
Venkateshappa, C.
Putta, R.
Pendyala, M.
Jadhav, T.
Wani, A. E.
Ghanta, S.
Birudukota, S.
Gogoi, H.
Nadig, H.
Gangaiah, R.
Mohd, Z.
Athisayamani, J.
Rajagopal, S.
EUROPEAN JOURNAL OF CANCER, 2018, 103 : E79 - E79
[36] Novel, heterocyclic small molecule inhibitors of PD-1 and PD-L1 pathway
Dhanalakshmi, Sivanandhan
Garapaty, Shivani
Venkateshappa, Chandregowda
Seerapu, Guru Pavan
Das, Reshma
Nagaraj, Pradeep
Kar, Ronodip
Singh, Anuj Kumar
Venkatesubbiah, Venkatesha Ashokkumar
Putta, Ramakishore V. P.
Pendyala, Muralidhar
Lokesh, Girisha
Madaka, Hari
Thummuru, Harikrishna Reddy
Shikas, A. P.
Anchan, Prateeksha
Bhat, Prathima
Rudresha, G.
Zainuddin, Mohd
Krishnakumar, V
Gosu, Ramachandraiah
Kristam, Rajendra
Jeyaraj, D. A.
Rajagopal, Sriram
CANCER RESEARCH, 2018, 78 (13)
[37] Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway
Qian Wu
Li Jiang
Si-cheng Li
Qiao-jun He
Bo Yang
Ji Cao
Acta Pharmacologica Sinica, 2021, 42 : 1 - 9
[38] A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy
Wang, Yuanyuan
Gu, Tingxuan
Tian, Xueli
Li, Wenwen
Zhao, Ran
Yang, Wenqian
Gao, Quanli
Li, Tiepeng
Shim, Jung-Hyun
Zhang, Chengjuan
Liu, Kangdong
Lee, Mee-Hyun
FRONTIERS IN IMMUNOLOGY, 2021, 12
[39] Identification of the FDA-Approved Drug Pyrvinium as a Small-Molecule Inhibitor of the PD-1/PD-L1 Interaction
Fattakhova, Elena
Hofer, Jeremy
DiFlumeri, Juliette
Cobb, Madison
Dando, Timothy
Romisher, Zachary
Wellington, Justin
Oravic, Michael
Radnoff, Madison
Patil, Sachin P.
CHEMMEDCHEM, 2021, 16 (18) : 2769 - 2774
[40] Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization
Guo, Yan
Jin, Yulong
Wang, Bingfeng
Liu, Boping
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)

← 1 2 3 4 5 →